Non-AIDS events under antiretroviral therapy (ART) are attributed to persistent low-grade inflammation. The magnitude of this inflammation is still discussed, partly because there is no standard value for “basal inflammation”. Here we compared the inflammation profile of HIV-infected patients under long-term suppressive ART to 2 well-characterised HIV-uninfected groups, at low and high risk of HIV acquisition.
HIV participants followed since acute/early HIV infection (AHI) in the ANRS PRIMO cohort were selected if treated for ≥36 months with sustained HIV RNA<50 copies/mL and available frozen samples. Sex and age-matched controls were sampled from the ANRS IPERGAY trial of pre-exposure prophylaxis among men who have sex with men at high risk for HIV infection, and the ANRS COHVAC cohort, a long-term safety cohort of volunteers in preventive HIV-1 vaccine trials. Participants with HBV or HCV infection were excluded. We compared the three groups on plasma levels of ten biomarkers: non-specific markers of inflammation (usCRP, IL6, TNFα, sTNFRII), and markers associated with monocyte activation (sCD14, sCD163, CXCL10), gut epithelial dysfunction (I-FABP, IL17) or fibrosis (hyaluronic acid). We also measured plasma ultrasensitive HIV RNA and total HIV DNA in blood. Analyses were performed separately for men and women.
150 PRIMO subjects (108 men and 42 women) were matched with 141 COHVAC participants (100 men, 41 women) and 102 IPERGAY men. The median age was 47 years. Among PRIMO subjects, 89% had CD4 counts >500 cells/µL and 64% had an undetectable ultrasensitive viral load after a median of 6 years of ART. Smoking and alcohol use were less frequent in COHVAC participants than in the other groups. After adjusting for age, smoking, alcohol use, and body mass index, both HIV-infected men and women had higher levels of sCD14, sCD163, CXCL10, sTNFRII and I-FABP than their non-HIV counterparts. When comparing the two non-HIV groups, IPERGAY men had significantly higher levels of IL17 and TNFα than COHVAC men. Inflammatory levels in HIV subjects were not associated with time since AHI diagnosis, cumulative ART duration, delay of ART initiation, residual viral replication and HIV DNA levels.
After a median of 6 years under ART, HIV-infected participants maintained high levels of monocyte activation and gut epithelial dysfunction.